720. Deputy John McGuinness asked the Minister for Health if the provision for reimbursement support under the community drug scheme for a continuous glucose monitoring device will be extended beyond patients with type 1 diabetes to include patients with reactive hypoglycaemia; the number of patients affected by hypoglycaemia; and the estimated cost of including this cohort; and if she will make a statement on the matter. [68260/26]

Summary

720. Deputy John McGuinness asked the Minister for Health if the provision for reimbursement support under the community drug scheme for a continuous glucose monitoring device will be extended beyond patients with type 1 diabetes to include patients with reactive hypoglycaemia; the number of patients affected by hypoglycaemia; and the estimated cost of including this cohort; and if she will make a statement on the matter. [68260/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 29 September 2026

   Disease Management

   720. Deputy John McGuinness asked the Minister for Health if the provision for reimbursement support under the community drug scheme for a continuous glucose monitoring device will be extended beyond patients with type 1 diabetes to include patients with reactive hypoglycaemia; the number of patients affected by hypoglycaemia; and the estimated cost of including this cohort; and if she will make a statement on the matter. [68260/26]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Disease Management

  xml · EN · 29 September 2026

  ViewDownloadOpen at official source

Sponsors

• John McGuinness · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.